BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31383386)

  • 1. Opportunities to reduce reoperations and to improve inter-facility profiling after initial breast-conserving surgery for cancer. A report from the NCDB.
    Landercasper J; Bennie B; Ahmad HF; Linebarger JH
    Eur J Surg Oncol; 2019 Nov; 45(11):2026-2036. PubMed ID: 31383386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated with Reoperation in Breast-Conserving Surgery for Cancer: A Prospective Study of American Society of Breast Surgeon Members.
    Landercasper J; Borgert AJ; Fayanju OM; Cody H; Feldman S; Greenberg C; Linebarger J; Pockaj B; Wilke L
    Ann Surg Oncol; 2019 Oct; 26(10):3321-3336. PubMed ID: 31342360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer.
    Chung A; Gangi A; Amersi F; Bose S; Zhang X; Giuliano A
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S422-7. PubMed ID: 26310280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of positive margins after initial lumpectomy in elderly women with breast cancer.
    Angarita FA; Acuna SA; McCready DR; Escallon J
    Eur J Surg Oncol; 2018 Jul; 44(7):1048-1053. PubMed ID: 29525464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice.
    Welsh JL; Hoskin TL; Day CN; Habermann EB; Goetz MP; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2881-2888. PubMed ID: 28766197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
    Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
    J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer.
    Park TS; Thomas SM; Rosenberger LH; Fayanju OM; Plichta JK; Blitzblau RC; Ong CT; Hyslop T; Hwang ES; Greenup RA
    Ann Surg Oncol; 2018 Oct; 25(10):3019-3029. PubMed ID: 29978365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.
    Rosenberger LH; Mamtani A; Fuzesi S; Stempel M; Eaton A; Morrow M; Gemignani ML
    Ann Surg Oncol; 2016 Oct; 23(10):3239-46. PubMed ID: 27411549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres.
    Angarita FA; Chesney T; Elser C; Mulligan AM; McCready DR; Escallon J
    Eur J Surg Oncol; 2015 May; 41(5):625-34. PubMed ID: 25727372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Residual Tumor in Breast-Conserving Therapy.
    Rath MG; Uhlmann L; Heil J; Domschke C; Roth Z; Sinn HP; Marme F; Scharf A; Schneeweiss A; Kieser M; Sohn C; Rom J
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S451-8. PubMed ID: 26224405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy.
    Petruolo OA; Pilewskie M; Patil S; Barrio AV; Stempel M; Wen HY; Morrow M
    Ann Surg Oncol; 2017 Sep; 24(9):2556-2562. PubMed ID: 28560596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Neoadjuvant Chemotherapy on Margin Re-excision in Breast-Conserving Surgery.
    Devane LA; Baban CK; O'Doherty A; Quinn C; McDermott EW; Prichard RS
    World J Surg; 2020 May; 44(5):1547-1551. PubMed ID: 32002582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.
    van Deurzen CH
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):627-633. PubMed ID: 27590331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy.
    Jia H; Jia W; Yang Y; Li S; Feng H; Liu J; Rao N; Jin L; Wu J; Gu R; Zhu L; Chen K; Deng H; Zeng Y; Liu Q; Song E; Su F
    World J Surg Oncol; 2014 Sep; 12():289. PubMed ID: 25241216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of intra-operative margin management techniques in breast-conserving surgery: a standardised approach reduces the likelihood of residual disease without increasing operative time.
    Bolger JC; Solon JG; Khan SA; Hill AD; Power CP
    Breast Cancer; 2015 May; 22(3):262-8. PubMed ID: 23649303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of lobular carcinoma from a national screening program: a retrospective analysis.
    Sharma SD; Barry M; O'Reilly EA; Kell MR
    Eur J Surg Oncol; 2015 Jan; 41(1):79-85. PubMed ID: 25441933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer.
    Ajmani GS; James TA; Kantor O; Wang CH; Yao KA
    Ann Surg Oncol; 2017 Oct; 24(11):3157-3166. PubMed ID: 28685357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of re-excision among women undergoing breast-conserving surgery for cancer.
    Waljee JF; Hu ES; Newman LA; Alderman AK
    Ann Surg Oncol; 2008 May; 15(5):1297-303. PubMed ID: 18259820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.